Clinical Trial Update: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of ribociclib in patients with advanced liposarcoma, including well-differentiated and dedifferentiate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma
• Liposarcoma
• Soft Tissue Sarcoma
• Well-differentiated Liposarcoma

Drugs mentioned

• KISQALI (ribociclib)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Liposarcomas, Dedifferentiated, Liposarcoma - Well Differentiated | Phase 2 | Status: UNKNOWN